# COMPAS (Clinical Otitis Media & Pneumonia Study): Pneumonia & Acute Otitis Media (AOM ) Efficacy Study of the Pneumococcal Conjugate Vaccine

> **NCT00466947** · PHASE3 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 23802 (actual)

## Conditions studied

- Infections, Streptococcal

## Interventions

- **BIOLOGICAL:** Pneumococcal conjugate vaccine GSK1024850A
- **BIOLOGICAL:** Havrix
- **BIOLOGICAL:** Engerix-B
- **BIOLOGICAL:** Infanrix hexa
- **BIOLOGICAL:** GSK Biologicals' DTPa-IPV/Hib vaccine

## Key facts

- **NCT ID:** NCT00466947
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06-28
- **Primary completion:** 2010-08-31
- **Final completion:** 2011-07-28
- **Target enrollment:** 23802 (ACTUAL)
- **Last updated:** 2019-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00466947

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00466947, "COMPAS (Clinical Otitis Media & Pneumonia Study): Pneumonia & Acute Otitis Media (AOM ) Efficacy Study of the Pneumococcal Conjugate Vaccine". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00466947. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*